Dr. McClintock and Colleagues Reply

Shawn M. McClintock, Mustafa M. Husain, A. John Rush, Cynthia Claassen, Melanie M. Biggs, Rebecca G. Knapp, Martina Mueller, Max Fink, Samuel H. Bailine, Teresa A. Rummans, Shirlene Sampson, Georgios Petrides and Sarah H. Lisanby

MY ACCOUNT

X All Individual Users: You may have noticed, we have just launched our new website. We will be adding more features over the upcoming weeks that you will like, so there may be a few hiccups along the way. If this is your first time visiting since our relaunch, please reset your password so you can still access our journals and CME activities that we have been providing for over 80 years. If you have any questions or comments please contact us at webadmin@psychiatrist.com.

Depression
Dr. McClintock and Colleagues Reply

Dr. McClintock and Colleagues Reply

Shawn M. McClintock, Mustafa M. Husain, A. John Rush, Cynthia Claassen, Melanie M. Biggs, Rebecca G. Knapp, Martina Mueller, Max Fink, Samuel H. Bailine, Teresa A. Rummans, Shirlene Sampson, Georgios Petrides, Charles H. Kellner, and Sarah H. Lisanby

J Clin Psychiatry 2008;69(10):1662-1663

Dr. McClintock and Colleagues Reply

Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1: Psychopharmacology and Neurobiological Effects

In addition to altering one’s perception of reality, psychedelics may be useful for trea...

Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder and Retention in Outpatient Substance Use Disorder Treatment: A Retrospective Cohort Study

How does comorbid attention-deficit/hyperactivity disorder (ADHD) affect individuals with ...

Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2: Review of the Evidence

Could psychedelics such as psilocybin and LSD be useful in treating MDD or other psychiatr...

Dr. McClintock and Colleagues Reply

Sign-up to stay up-to-date today!

Already registered? Sign In

Sign-up to stay
up-to-date today!